Retinal Vein Occlusion – Epidemiology – Mature Markets Data
DRG Epidemiology's coverage of retinal vein occlusion comprises epidemiological estimates of key patient populations in the Mature Markets. We report the prevalence of retinal vein occlusion for each country as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 10 ten years for the other countries covered in this report. For the mature markets, the patient population is forecasted over a period of 20 twenty years.
DRG Epidemiology's retinal vein occlusion forecast will answer the following question:
How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of retinal vein occlusion over the forecast period?
All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
In addition to the total number of cases for each forecast year, DRG Epidemiology provides at least 20 years of forecast data for the following retinal vein occlusion subpopulations:
Total prevalent RVO cases by subtype scheme.
Total prevalent RVO cases with comorbid macular edema.
Retinal Vein Occlusion - Epidemiology - Mature Markets Data
Introduction
Key Findings
Prevalence of Retinal Vein Occlusion per 100 People Aged 40 or Older in 2018 and 2038ttttttttt
Relative Sizes of the Factors Contributing to the Trend in Prevalent Cases of Retinal Vein Occlusion Over the Next 20 Yearsttttttttt
Relative Sizes of the Factors Contributing to the Trend in Prevalent Cases of Retinal Vein Occlusion Over the Next 20 Yearsttttttttt
Analysis of the Prevalent Cases of Retinal Vein Occlusion in 2018 by Subtype Schemettttttttt
Epidemiology Data
Methods
Total Prevalent Cases of Retinal Vein Occlusion
Total Prevalent Cases by Subtype Scheme
Total Prevalent Cases with Comorbid Macular Edema
Reference Materials
Literature Review
Studies Excluded from the Analysis of Retinal Vein Occlusion
Risk/Protective Factors
Risk/Protective Factors for Retinal Vein Occlusion
Bibliography
Ravdeep Kaur, M.P.H.
Ravdeep Kaur, M.P.H., is an associate epidemiologist at DRG, part of Clarivate. She holds a master’s degree in public health from the School of Public Health at the Post-Graduate Institute of Medical Education and Research and a bachelor’s degree in dental surgery from Rajiv Gandhi University of Health Sciences in India. Prior to joining DRG, she was a consultant for the Reproductive, Maternal, Child, and Adolescent Health Program, funded by the U.S. Agency for International Development.
Alison Isherwood, M.Sc., M.Res., Ph.D.
Alison Isherwood, M.Sc., M.Res., Ph.D., is a senior director on the Epidemiology team at Clarivate. She specializes in female cancers, biomarker, and infectious disease epidemiology, particularly involving the impact of vaccination. She holds a B.Sc. in medical microbiology, a master’s degree in research in the life sciences (specializing in virology and parasitology), and an M.Sc. in epidemiology, all from the University of Edinburgh. She also holds a Ph.D. in molecular virology from the University of Reading in England.
